<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30205402</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>22</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1423-0356</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>96</Volume>                    <Issue>6</Issue>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Respiration; international review of thoracic diseases</Title>                <ISOAbbreviation>Respiration</ISOAbbreviation>            </Journal>            <ArticleTitle>Effect of Chemotherapy on Removal of Indwelling Pleural Catheters in Breast Cancer Patients with Malignant Pleural Effusions.</ArticleTitle>            <Pagination>                <MedlinePgn>552-559</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000491097</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Indwelling pleural catheters (IPC) are commonly used in the management of malignant pleural effusions (MPE). The effect of systemic chemotherapy on IPC removal has not been reported previously.</AbstractText>                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study is to identify the effect of chemotherapy on the removal of IPCs in breast cancer patients with MPEs.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective cohort study at an academic tertiary-care center, patients with breast cancer and MPE who received an IPC between 2006 and 2016 were identified from a prospectively collected database. Patient chemotherapy data were obtained, as well estrogen receptor (ER) and human epidermal growth factor receptor-2 status at the time of diagnosis. Patients receiving chemotherapy while their IPC was in situ were compared to those who did not. The primary outcome was time to IPC removal. All patients were followed until IPC removal or death.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 207 patients and 216 IPCs were included in the analysis. There was no difference in time to IPC removal between the chemotherapy and no-chemotherapy groups (HR 0.73, 95% CI 0.50-1.07, p = 0.10) or rate of IPC removal (OR 1.16, 95% CI 0.68-1.98, p = 0.59). The risk of IPC infection was not different between patients who received chemotherapy and those who did not (RR 0.57, 95% CI 0.06-5.39, p = 0.48).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Treatment with chemotherapy with an IPC in situ was not associated with a reduced time to IPC removal in our breast cancer population. IPC insertion in patients receiving chemotherapy is safe and not associated with an increased risk of infection.</AbstractText>                <CopyrightInformation>Â© 2018 S. Karger AG, Basel.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Mitchell</LastName>                    <ForeName>Michael A</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Medicine, Division of Respirology, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Burkett</LastName>                    <ForeName>Andrew</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Medicine, Division of Respirology, University of Ottawa, Ottawa, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Pen</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, Division of Respirology, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Tinghua</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Amjadi</LastName>                    <ForeName>Kayvan</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>From the Department of Medicine, Division of Respirology, University of Ottawa, Ottawa, Ontario, Canadakamjadi@toh.ca.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>Respiration</MedlineTA>            <NlmUniqueID>0137356</NlmUniqueID>            <ISSNLinking>0025-7931</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Cancer</Keyword>            <Keyword MajorTopicYN="N">Chemotherapy</Keyword>            <Keyword MajorTopicYN="N">Indwelling pleural catheter</Keyword>            <Keyword MajorTopicYN="N">PleurX</Keyword>            <Keyword MajorTopicYN="N">Pleural effusion</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30205402</ArticleId>            <ArticleId IdType="pii">000491097</ArticleId>            <ArticleId IdType="doi">10.1159/000491097</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>